Black and Latino youth were less likely to undergo an eye examination for diabetic retinopathy within 6 years of their diagnosis.
Cumulative probability of proliferative diabetic retinopathy worsening was 42% in the panretinal photocoagulation group compared with 34% in the ranibizumab group.
Patients with diabetic macular edema experienced lower total retinal blood flow than patients without.
There are fewer cases of incident diabetic retinopathy among obese patients with type 2 diabetes undergoing bariatric surgery compared with medical treatment.
Vitreous levels of alphaB-crystallin are significantly higher in eyes of patients with proliferative diabetic retinopathy (PDR) compared with the eyes of controls without diabetes.
Self-care tools can reduce depressive symptoms in patients with age-related macular degeneration or diabetic retinopathy.
An algorithm based on deep machine learning may help identify diabetic retinopathy and diabetic macular edema with high specificity and sensitivity.
Patients and health care providers have markedly divergent perceptions of barriers to diabetic retinopathy screening.
Treated diabetic retinopathy is extremely rare among children with type 1 diabetes, according to research published in Diabetes Care.
Researchers attributed nearly 5 million cases of blindness or impaired vision to complications from diabetes.
For patients with diabetes, 2 servings of fatty fish a week may be enough to lower their risk of diabetic retinopathy.
A study in Australia shows that general practitioners referred patients for a diabetic retinopathy screening on an average of 3.1 years after diabetes diagnosis.
Severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy, but not diabetic macular edema, is associated with depressive symptoms.
A statistically significant association was found between low vitamin D levels and the development of diabetic retinopathy.
For patients with diabetes, diabetic retinopathy screening varies for different minority groups, according to research published in Diabetes Care.
Among eyes with proliferative diabetic retinopathy, ranibizumab was noninferior to panretinal photocoagulation at 2 years.
No benefit seen with the diet for prevention of diabetic nephropathy.
Yearly exams for most with type 1 diabetes can wait until 5 years after diagnosis or age 15, whichever is later.
The FDA expanded the approval of Eylea (aflibercept; Regeneron) injection to treat diabetic retinopathy in patients with diabetic macular edema.
The FDA has approved ranibizumab injection (Lucentis) for treatment of diabetic retinopathy with diabetic macular edema.
About one in five patients were identified as having diabetic retinopathy through telemedicine screening.
The FDA has accepted the supplemental Biologics License Application and granted Priority Review for Lucentis for treatment of diabetic retinopathy.
Statins may help prevent microvascular complications, such as neuropathy, retinopathy and gangrene of the foot, associated with diabetes.
Endocrinology Advisor Articles
- Osteoporosis Care Quality Most Consistently Predicted By Primary Care
- Effect of Monthly High-Dose Vitamin D on CVD
- Accuracy of Trabecular Bone Score to Assess Fragility Fracture Risk in T1D
- Is DXA Required to Diagnose Vertebral Fracture in Patients With Low BMD?
- Increase in DPP-4i, Sulfonylurea Use in Diabetic Nephropathy
- Migraine Management in Female Reproduction
- Oral Levothyroxine Absorption Reduced By Cow's Milk Consumption
- Best of the 2017 Annual Meeting & Expo of the Endocrine Society
- Natural Therapies: Avocado Consumption for Metabolic Syndrome
- Hypovitaminosis D Associated With High 24-Hour Ambulatory BP in Type 2 Diabetes
- Gestational Diabetes Risk May Be Reduced With Probiotics
- Heart Failure Risk Association with BMI and Cardiorespiratory Fitness
- Driving Risk Assessment for Patients With Type 1 Diabetes
- Statin Intolerance Contributes to Higher Risk for MI and CHD
- Preeclampsia Increases Pregnancy-Associated Stroke Risk